<?xml version="1.0" encoding="UTF-8"?>
<ref id="B137-vaccines-07-00203">
 <label>137.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Friberg</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Burns</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Woda</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Kalayanarooj</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Endy</surname>
    <given-names>T.P.</given-names>
   </name>
   <name>
    <surname>Stephens</surname>
    <given-names>H.A.F.</given-names>
   </name>
   <name>
    <surname>Green</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Rothman</surname>
    <given-names>A.L.</given-names>
   </name>
   <name>
    <surname>Mathew</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Memory CD8+ T cells from naturally acquired primary dengue virus infection are highly cross-reactive</article-title>
  <source>Immunol. Cell Biol.</source>
  <year>2011</year>
  <volume>89</volume>
  <fpage>122</fpage>
  <lpage>129</lpage>
  <pub-id pub-id-type="doi">10.1038/icb.2010.61</pub-id>
  <pub-id pub-id-type="pmid">20421879</pub-id>
 </element-citation>
</ref>
